| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 157 | 2021 | 13337 | 7.300 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 76 | 2021 | 5302 | 5.580 |
Why?
|
| Adenocarcinoma | 69 | 2018 | 6339 | 4.250 |
Why?
|
| Quinazolines | 26 | 2016 | 1371 | 3.650 |
Why?
|
| Taiwan | 45 | 2020 | 516 | 2.380 |
Why?
|
| Mutation | 50 | 2021 | 30045 | 1.730 |
Why?
|
| Small Cell Lung Carcinoma | 6 | 2018 | 422 | 1.440 |
Why?
|
| Genes, erbB-1 | 5 | 2014 | 162 | 1.410 |
Why?
|
| Severe Acute Respiratory Syndrome | 6 | 2006 | 137 | 1.350 |
Why?
|
| Antineoplastic Agents | 31 | 2021 | 13637 | 1.240 |
Why?
|
| Protein Kinase Inhibitors | 18 | 2021 | 5665 | 1.200 |
Why?
|
| Neoplasm Invasiveness | 23 | 2016 | 3589 | 1.060 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 3 | 2014 | 89 | 1.010 |
Why?
|
| Antitubercular Agents | 7 | 2015 | 1374 | 1.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 28 | 2020 | 8545 | 0.970 |
Why?
|
| Aged | 148 | 2020 | 169235 | 0.970 |
Why?
|
| Aged, 80 and over | 80 | 2018 | 58956 | 0.950 |
Why?
|
| Prognosis | 47 | 2017 | 29620 | 0.920 |
Why?
|
| Ventilator Weaning | 4 | 2008 | 163 | 0.910 |
Why?
|
| Middle Aged | 154 | 2020 | 220826 | 0.900 |
Why?
|
| Cell Movement | 14 | 2021 | 5203 | 0.880 |
Why?
|
| Carcinoma, Squamous Cell | 14 | 2021 | 4021 | 0.870 |
Why?
|
| Neoplasm Staging | 30 | 2017 | 11106 | 0.860 |
Why?
|
| Osteogenesis | 4 | 2021 | 1273 | 0.810 |
Why?
|
| Male | 177 | 2021 | 360736 | 0.810 |
Why?
|
| Lung Diseases | 7 | 2009 | 1909 | 0.810 |
Why?
|
| Biomarkers, Pharmacological | 2 | 2015 | 161 | 0.800 |
Why?
|
| Tuberculosis, Pulmonary | 7 | 2019 | 832 | 0.770 |
Why?
|
| Pleurodesis | 2 | 2014 | 46 | 0.770 |
Why?
|
| Female | 178 | 2020 | 392581 | 0.760 |
Why?
|
| Pneumothorax | 4 | 2014 | 383 | 0.750 |
Why?
|
| Pseudopodia | 2 | 2012 | 168 | 0.750 |
Why?
|
| Tuberculosis | 8 | 2015 | 2016 | 0.740 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 2 | 2012 | 113 | 0.740 |
Why?
|
| Periodontal Ligament | 1 | 2021 | 117 | 0.730 |
Why?
|
| Survival Analysis | 27 | 2019 | 10089 | 0.730 |
Why?
|
| Neoplasm Metastasis | 22 | 2020 | 4912 | 0.720 |
Why?
|
| Community-Acquired Infections | 5 | 2009 | 468 | 0.720 |
Why?
|
| Humans | 238 | 2021 | 761423 | 0.680 |
Why?
|
| Neoplastic Stem Cells | 6 | 2021 | 1347 | 0.670 |
Why?
|
| Guanine | 2 | 2011 | 279 | 0.670 |
Why?
|
| Genes, p53 | 3 | 2016 | 712 | 0.670 |
Why?
|
| Glutamates | 2 | 2011 | 389 | 0.670 |
Why?
|
| Nerve Tissue Proteins | 6 | 2017 | 4414 | 0.660 |
Why?
|
| Antigens, Neoplasm | 5 | 2016 | 1994 | 0.650 |
Why?
|
| Cell Line, Tumor | 35 | 2021 | 16979 | 0.630 |
Why?
|
| Adult | 105 | 2019 | 221148 | 0.620 |
Why?
|
| Lipopolysaccharides | 4 | 2021 | 2207 | 0.600 |
Why?
|
| Lung | 10 | 2017 | 9995 | 0.590 |
Why?
|
| DNA, Neoplasm | 7 | 2014 | 1745 | 0.580 |
Why?
|
| Mice, SCID | 16 | 2018 | 2626 | 0.580 |
Why?
|
| Respiration, Artificial | 7 | 2008 | 2625 | 0.570 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2016 | 4510 | 0.570 |
Why?
|
| Neoplasm Proteins | 7 | 2016 | 3612 | 0.550 |
Why?
|
| STAT1 Transcription Factor | 2 | 2016 | 340 | 0.540 |
Why?
|
| Neoplasm Recurrence, Local | 10 | 2019 | 9277 | 0.540 |
Why?
|
| Syntenins | 1 | 2016 | 8 | 0.530 |
Why?
|
| Oncogene Proteins, Fusion | 5 | 2016 | 1606 | 0.530 |
Why?
|
| Transcription Factors | 9 | 2017 | 12125 | 0.530 |
Why?
|
| DNA Mutational Analysis | 16 | 2016 | 4110 | 0.520 |
Why?
|
| Sputum | 4 | 2013 | 507 | 0.520 |
Why?
|
| Kaplan-Meier Estimate | 12 | 2017 | 6479 | 0.510 |
Why?
|
| Disease-Free Survival | 17 | 2018 | 6814 | 0.510 |
Why?
|
| Polymorphism, Genetic | 8 | 2016 | 4287 | 0.510 |
Why?
|
| Epithelial-Mesenchymal Transition | 5 | 2018 | 736 | 0.510 |
Why?
|
| Gene Dosage | 3 | 2016 | 1218 | 0.510 |
Why?
|
| NF-kappa B | 3 | 2021 | 2488 | 0.510 |
Why?
|
| Bronchoscopy | 3 | 2013 | 909 | 0.500 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2016 | 4575 | 0.500 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2021 | 946 | 0.500 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 6 | 2013 | 3204 | 0.500 |
Why?
|
| Empyema, Pleural | 2 | 2005 | 61 | 0.490 |
Why?
|
| Intensive Care Units | 9 | 2010 | 3744 | 0.490 |
Why?
|
| Heparin Cofactor II | 1 | 2014 | 3 | 0.490 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2015 | 114 | 0.490 |
Why?
|
| Receptor, erbB-3 | 1 | 2016 | 143 | 0.490 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 282 | 0.480 |
Why?
|
| Survival Rate | 18 | 2016 | 12720 | 0.480 |
Why?
|
| MicroRNAs | 6 | 2014 | 3812 | 0.480 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2016 | 2423 | 0.470 |
Why?
|
| Receptors, Steroid | 1 | 2015 | 156 | 0.470 |
Why?
|
| Radiotherapy | 2 | 2020 | 1499 | 0.470 |
Why?
|
| Epistasis, Genetic | 1 | 2016 | 352 | 0.470 |
Why?
|
| Interleukin-15 | 1 | 2015 | 185 | 0.470 |
Why?
|
| Influenza Vaccines | 2 | 2012 | 767 | 0.470 |
Why?
|
| Mycobacterium tuberculosis | 7 | 2013 | 1913 | 0.460 |
Why?
|
| ras Proteins | 7 | 2015 | 1053 | 0.460 |
Why?
|
| Gene Expression | 5 | 2016 | 7584 | 0.460 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2016 | 618 | 0.450 |
Why?
|
| Codon | 1 | 2016 | 602 | 0.450 |
Why?
|
| Drug Resistance, Neoplasm | 11 | 2018 | 5305 | 0.450 |
Why?
|
| Critical Illness | 4 | 2010 | 2723 | 0.450 |
Why?
|
| Signal Transduction | 12 | 2021 | 23441 | 0.440 |
Why?
|
| Treatment Outcome | 44 | 2018 | 64651 | 0.440 |
Why?
|
| Cell Adhesion Molecules | 2 | 2012 | 1600 | 0.440 |
Why?
|
| Carcinoma | 3 | 2015 | 2330 | 0.430 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2014 | 379 | 0.430 |
Why?
|
| Antibiotics, Antitubercular | 2 | 2011 | 99 | 0.430 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2014 | 183 | 0.430 |
Why?
|
| Minocycline | 1 | 2014 | 169 | 0.430 |
Why?
|
| Lymphopenia | 1 | 2015 | 280 | 0.420 |
Why?
|
| Immunohistochemistry | 14 | 2021 | 11073 | 0.420 |
Why?
|
| HSP40 Heat-Shock Proteins | 3 | 2010 | 82 | 0.410 |
Why?
|
| Paracrine Communication | 1 | 2014 | 276 | 0.410 |
Why?
|
| Thymidylate Synthase | 2 | 2016 | 74 | 0.410 |
Why?
|
| Carcinoma, Large Cell | 3 | 2010 | 113 | 0.410 |
Why?
|
| Mycobacterium chelonae | 1 | 2011 | 12 | 0.400 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 7 | 2016 | 1743 | 0.390 |
Why?
|
| Sp1 Transcription Factor | 2 | 2010 | 140 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2011 | 310 | 0.380 |
Why?
|
| Specimen Handling | 2 | 2013 | 702 | 0.370 |
Why?
|
| Proportional Hazards Models | 14 | 2016 | 12456 | 0.370 |
Why?
|
| Polymorphism, Single Nucleotide | 19 | 2017 | 15941 | 0.370 |
Why?
|
| Apoptosis | 13 | 2021 | 9488 | 0.360 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2011 | 133 | 0.360 |
Why?
|
| Smoking | 21 | 2020 | 9052 | 0.360 |
Why?
|
| Hemothorax | 1 | 2010 | 57 | 0.360 |
Why?
|
| Curcumin | 1 | 2011 | 98 | 0.360 |
Why?
|
| Rifampin | 2 | 2011 | 339 | 0.350 |
Why?
|
| Fibroblasts | 4 | 2021 | 4140 | 0.350 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2012 | 178 | 0.350 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2014 | 2916 | 0.350 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 5 | 2007 | 587 | 0.350 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 5 | 2016 | 1624 | 0.340 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 411 | 0.340 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2014 | 592 | 0.340 |
Why?
|
| Thorax | 1 | 2013 | 555 | 0.340 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 2009 | 21 | 0.330 |
Why?
|
| Anti-Bacterial Agents | 9 | 2014 | 7409 | 0.330 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 9 | 2016 | 11740 | 0.330 |
Why?
|
| APACHE | 6 | 2010 | 267 | 0.330 |
Why?
|
| Genetic Predisposition to Disease | 17 | 2019 | 17912 | 0.320 |
Why?
|
| Creatinine | 1 | 2015 | 1899 | 0.320 |
Why?
|
| Picibanil | 1 | 2008 | 10 | 0.320 |
Why?
|
| Oncogene Proteins | 1 | 2013 | 718 | 0.320 |
Why?
|
| Cadherins | 5 | 2013 | 904 | 0.320 |
Why?
|
| Biopsy, Needle | 2 | 2012 | 1626 | 0.320 |
Why?
|
| Pregnancy Proteins | 1 | 2009 | 222 | 0.310 |
Why?
|
| Fluoroquinolones | 2 | 2009 | 307 | 0.310 |
Why?
|
| Pleural Effusion | 2 | 2009 | 342 | 0.310 |
Why?
|
| Drainage | 1 | 2014 | 1156 | 0.310 |
Why?
|
| Respiratory System | 2 | 2009 | 563 | 0.310 |
Why?
|
| Matrix Metalloproteinases | 2 | 2020 | 392 | 0.310 |
Why?
|
| Membrane Proteins | 7 | 2017 | 7856 | 0.310 |
Why?
|
| Cyclooxygenase 2 | 2 | 2008 | 597 | 0.310 |
Why?
|
| Interleukin-8 | 3 | 2015 | 695 | 0.310 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 687 | 0.300 |
Why?
|
| Multivariate Analysis | 12 | 2015 | 12058 | 0.300 |
Why?
|
| Blotting, Western | 7 | 2021 | 5036 | 0.300 |
Why?
|
| Papilloma | 1 | 2009 | 140 | 0.300 |
Why?
|
| Retrospective Studies | 36 | 2017 | 80582 | 0.300 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2008 | 130 | 0.300 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2013 | 2803 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2010 | 368 | 0.290 |
Why?
|
| Radiology, Interventional | 1 | 2012 | 476 | 0.290 |
Why?
|
| Salvage Therapy | 3 | 2017 | 1264 | 0.290 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2019 | 1076 | 0.290 |
Why?
|
| Nanotubes, Carbon | 1 | 2008 | 71 | 0.290 |
Why?
|
| Sepsis | 3 | 2015 | 2585 | 0.290 |
Why?
|
| Pneumonia, Bacterial | 2 | 2010 | 316 | 0.280 |
Why?
|
| Gene Expression Profiling | 7 | 2016 | 9418 | 0.280 |
Why?
|
| Meningitis | 1 | 2009 | 217 | 0.280 |
Why?
|
| Cytokines | 5 | 2013 | 7392 | 0.280 |
Why?
|
| Biopsy | 2 | 2017 | 6766 | 0.280 |
Why?
|
| Ipratropium | 1 | 2006 | 19 | 0.280 |
Why?
|
| Scopolamine Derivatives | 1 | 2006 | 24 | 0.280 |
Why?
|
| Neoplasm Transplantation | 5 | 2021 | 2016 | 0.280 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2009 | 412 | 0.280 |
Why?
|
| Cell Proliferation | 14 | 2021 | 10441 | 0.280 |
Why?
|
| Abdomen | 1 | 2013 | 1128 | 0.270 |
Why?
|
| Mice, Inbred NOD | 6 | 2018 | 1827 | 0.270 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 2821 | 0.270 |
Why?
|
| Mitochondria | 2 | 2021 | 3623 | 0.270 |
Why?
|
| Animals | 38 | 2021 | 168441 | 0.270 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2009 | 169 | 0.270 |
Why?
|
| Empyema | 1 | 2006 | 41 | 0.270 |
Why?
|
| Vimentin | 2 | 2021 | 255 | 0.270 |
Why?
|
| Mice | 28 | 2021 | 81509 | 0.260 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 1036 | 0.260 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2007 | 239 | 0.260 |
Why?
|
| Receptor, erbB-2 | 2 | 2016 | 2557 | 0.260 |
Why?
|
| Adrenal Insufficiency | 1 | 2008 | 194 | 0.260 |
Why?
|
| Sequence Deletion | 5 | 2016 | 1494 | 0.260 |
Why?
|
| Cell Survival | 6 | 2021 | 5790 | 0.260 |
Why?
|
| Legionnaires' Disease | 1 | 2006 | 49 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2021 | 10766 | 0.260 |
Why?
|
| Mouth Neoplasms | 2 | 2021 | 596 | 0.260 |
Why?
|
| Telomerase | 2 | 2014 | 745 | 0.260 |
Why?
|
| Movement | 1 | 2013 | 1478 | 0.260 |
Why?
|
| Respiration | 2 | 2013 | 1657 | 0.260 |
Why?
|
| Cholinergic Antagonists | 1 | 2006 | 168 | 0.250 |
Why?
|
| Walking | 1 | 2013 | 1200 | 0.250 |
Why?
|
| Hepatitis B | 1 | 2011 | 706 | 0.250 |
Why?
|
| Antigens, CD | 1 | 2016 | 4001 | 0.250 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2021 | 3602 | 0.250 |
Why?
|
| Enzyme Activation | 5 | 2016 | 3597 | 0.250 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 479 | 0.250 |
Why?
|
| Endosonography | 1 | 2009 | 609 | 0.250 |
Why?
|
| Culture Media | 1 | 2007 | 896 | 0.250 |
Why?
|
| Inflammasomes | 2 | 2020 | 525 | 0.250 |
Why?
|
| Polymerase Chain Reaction | 8 | 2016 | 6086 | 0.250 |
Why?
|
| Mycobacterium Infections | 1 | 2005 | 122 | 0.250 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2065 | 0.250 |
Why?
|
| Salmonella | 1 | 2005 | 125 | 0.240 |
Why?
|
| Laryngeal Neoplasms | 1 | 2009 | 514 | 0.240 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2008 | 279 | 0.240 |
Why?
|
| Neovascularization, Pathologic | 5 | 2020 | 2644 | 0.240 |
Why?
|
| Base Sequence | 10 | 2013 | 12450 | 0.240 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2007 | 330 | 0.240 |
Why?
|
| China | 7 | 2020 | 2366 | 0.240 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2020 | 2863 | 0.240 |
Why?
|
| Respiratory Insufficiency | 2 | 2004 | 1230 | 0.240 |
Why?
|
| Hospitals, University | 5 | 2010 | 563 | 0.230 |
Why?
|
| Pneumoconiosis | 1 | 2004 | 32 | 0.230 |
Why?
|
| Coal Mining | 1 | 2004 | 12 | 0.230 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 318 | 0.230 |
Why?
|
| Reactive Oxygen Species | 3 | 2021 | 2141 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3639 | 0.230 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 362 | 0.230 |
Why?
|
| Osteoblasts | 2 | 2020 | 1143 | 0.230 |
Why?
|
| Pulmonary Emphysema | 1 | 2009 | 685 | 0.230 |
Why?
|
| Genotype | 12 | 2017 | 13009 | 0.230 |
Why?
|
| Carcinoma, Small Cell | 2 | 2005 | 420 | 0.230 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2016 | 223 | 0.230 |
Why?
|
| Pyrazoles | 1 | 2014 | 2007 | 0.230 |
Why?
|
| Exons | 5 | 2016 | 2393 | 0.220 |
Why?
|
| Immunoassay | 1 | 2007 | 746 | 0.220 |
Why?
|
| Exanthema | 1 | 2008 | 503 | 0.220 |
Why?
|
| Cohort Studies | 16 | 2020 | 41446 | 0.220 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2017 | 3779 | 0.220 |
Why?
|
| Transfection | 8 | 2019 | 5775 | 0.220 |
Why?
|
| Rats, Wistar | 3 | 2021 | 1847 | 0.220 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 1 | 2002 | 8 | 0.210 |
Why?
|
| Genome-Wide Association Study | 16 | 2020 | 12688 | 0.210 |
Why?
|
| Nuclear Proteins | 3 | 2016 | 5794 | 0.210 |
Why?
|
| Acinetobacter Infections | 1 | 2003 | 73 | 0.210 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2019 | 621 | 0.210 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 9606 | 0.210 |
Why?
|
| Bronchodilator Agents | 1 | 2006 | 512 | 0.210 |
Why?
|
| Stomach Neoplasms | 1 | 2013 | 1459 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2014 | 386 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2009 | 3490 | 0.210 |
Why?
|
| Case-Control Studies | 16 | 2020 | 22168 | 0.210 |
Why?
|
| Sickness Impact Profile | 1 | 2004 | 299 | 0.210 |
Why?
|
| Pneumonia, Aspiration | 1 | 2003 | 145 | 0.210 |
Why?
|
| Pyridines | 1 | 2014 | 2875 | 0.210 |
Why?
|
| Methylprednisolone | 1 | 2004 | 384 | 0.210 |
Why?
|
| Molecular Sequence Data | 9 | 2012 | 17644 | 0.200 |
Why?
|
| Chemokines | 1 | 2006 | 959 | 0.200 |
Why?
|
| Acinetobacter baumannii | 1 | 2003 | 118 | 0.200 |
Why?
|
| Rhabdomyolysis | 1 | 2003 | 152 | 0.200 |
Why?
|
| Macrophages, Alveolar | 1 | 2004 | 412 | 0.200 |
Why?
|
| Shock, Septic | 1 | 2009 | 768 | 0.200 |
Why?
|
| Renin-Angiotensin System | 1 | 2007 | 737 | 0.200 |
Why?
|
| Mosaicism | 2 | 2016 | 475 | 0.200 |
Why?
|
| Gene Frequency | 5 | 2016 | 3647 | 0.200 |
Why?
|
| RNA Interference | 5 | 2017 | 2831 | 0.200 |
Why?
|
| High-Frequency Jet Ventilation | 1 | 2002 | 26 | 0.200 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2018 | 506 | 0.200 |
Why?
|
| Radiation Pneumonitis | 1 | 2002 | 102 | 0.200 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2016 | 898 | 0.200 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2008 | 1048 | 0.200 |
Why?
|
| Nephrotic Syndrome | 1 | 2006 | 391 | 0.200 |
Why?
|
| Rotation | 1 | 2003 | 517 | 0.200 |
Why?
|
| Viral Load | 1 | 2011 | 3330 | 0.200 |
Why?
|
| Lymphatic Metastasis | 4 | 2015 | 2914 | 0.200 |
Why?
|
| Time Factors | 14 | 2015 | 39975 | 0.200 |
Why?
|
| Sincalide | 1 | 2021 | 15 | 0.190 |
Why?
|
| Predictive Value of Tests | 8 | 2017 | 15262 | 0.190 |
Why?
|
| Follow-Up Studies | 12 | 2017 | 39117 | 0.190 |
Why?
|
| Prospective Studies | 16 | 2015 | 54415 | 0.190 |
Why?
|
| Esterases | 1 | 2021 | 98 | 0.190 |
Why?
|
| Mucins | 1 | 2005 | 568 | 0.190 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 796 | 0.190 |
Why?
|
| Tumor Microenvironment | 4 | 2021 | 3874 | 0.190 |
Why?
|
| Parkinson Disease | 1 | 2015 | 2877 | 0.190 |
Why?
|
| Logistic Models | 11 | 2016 | 13255 | 0.190 |
Why?
|
| Pleural Effusion, Malignant | 2 | 2012 | 106 | 0.190 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2021 | 133 | 0.190 |
Why?
|
| Cell Count | 2 | 2021 | 1835 | 0.180 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2013 | 473 | 0.180 |
Why?
|
| Length of Stay | 4 | 2008 | 6422 | 0.180 |
Why?
|
| Mandibular Diseases | 1 | 2021 | 119 | 0.180 |
Why?
|
| RNA, Messenger | 6 | 2008 | 12796 | 0.180 |
Why?
|
| Hepatitis C | 1 | 2011 | 1584 | 0.180 |
Why?
|
| Protein Binding | 5 | 2016 | 9352 | 0.180 |
Why?
|
| Chest Tubes | 3 | 2010 | 152 | 0.180 |
Why?
|
| Genetic Loci | 3 | 2016 | 2631 | 0.180 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2002 | 131 | 0.180 |
Why?
|
| Tracheostomy | 1 | 2004 | 426 | 0.180 |
Why?
|
| Cross Infection | 3 | 2006 | 1421 | 0.180 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2021 | 93 | 0.180 |
Why?
|
| RNA, Small Interfering | 5 | 2014 | 3428 | 0.180 |
Why?
|
| Pulmonary Alveoli | 1 | 2003 | 650 | 0.180 |
Why?
|
| Cells, Cultured | 6 | 2021 | 18964 | 0.170 |
Why?
|
| Hydrocortisone | 1 | 2008 | 1815 | 0.170 |
Why?
|
| Laminin | 2 | 2013 | 408 | 0.170 |
Why?
|
| Physical Therapy Modalities | 1 | 2003 | 532 | 0.170 |
Why?
|
| Allyl Compounds | 1 | 2019 | 22 | 0.170 |
Why?
|
| Risk Factors | 18 | 2020 | 74167 | 0.170 |
Why?
|
| Synovitis | 1 | 2021 | 217 | 0.170 |
Why?
|
| Disease Progression | 7 | 2020 | 13502 | 0.170 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 3798 | 0.170 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 673 | 0.170 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2008 | 1723 | 0.170 |
Why?
|
| Peptides, Cyclic | 1 | 2021 | 392 | 0.160 |
Why?
|
| Age Factors | 6 | 2014 | 18400 | 0.160 |
Why?
|
| Drug Repositioning | 1 | 2021 | 233 | 0.160 |
Why?
|
| Bronchi | 2 | 2013 | 845 | 0.160 |
Why?
|
| Asia | 3 | 2020 | 619 | 0.160 |
Why?
|
| Up-Regulation | 6 | 2016 | 4124 | 0.160 |
Why?
|
| Glucocorticoids | 2 | 2010 | 2161 | 0.160 |
Why?
|
| Antibodies, Viral | 2 | 2011 | 3155 | 0.160 |
Why?
|
| Odds Ratio | 9 | 2016 | 9645 | 0.160 |
Why?
|
| Lymphokines | 1 | 2002 | 927 | 0.160 |
Why?
|
| Cholesterol, HDL | 1 | 2005 | 1814 | 0.160 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2020 | 259 | 0.160 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 18247 | 0.160 |
Why?
|
| Autophagy | 3 | 2021 | 1326 | 0.150 |
Why?
|
| Ticlopidine | 1 | 2003 | 730 | 0.150 |
Why?
|
| Sumoylation | 1 | 2019 | 83 | 0.150 |
Why?
|
| Transplantation, Heterologous | 5 | 2017 | 2386 | 0.150 |
Why?
|
| Heme Oxygenase-1 | 1 | 2020 | 365 | 0.150 |
Why?
|
| Spleen | 1 | 2004 | 2295 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 1934 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 1613 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 373 | 0.150 |
Why?
|
| Autonomic Nervous System | 1 | 2003 | 701 | 0.150 |
Why?
|
| Osteoclasts | 1 | 2021 | 711 | 0.150 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2021 | 1642 | 0.150 |
Why?
|
| Bacteria | 1 | 2008 | 2199 | 0.150 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2017 | 145 | 0.140 |
Why?
|
| Disulfides | 1 | 2019 | 465 | 0.140 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2016 | 2054 | 0.140 |
Why?
|
| Immunoglobulin G | 2 | 2007 | 4549 | 0.140 |
Why?
|
| Osteosarcoma | 2 | 2020 | 897 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2021 | 2455 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 3810 | 0.140 |
Why?
|
| Vitamin D | 2 | 2020 | 3301 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2009 | 1610 | 0.140 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 20093 | 0.140 |
Why?
|
| Chromosome Aberrations | 2 | 2015 | 1771 | 0.140 |
Why?
|
| Bacteremia | 1 | 2003 | 978 | 0.130 |
Why?
|
| Young Adult | 14 | 2017 | 59207 | 0.130 |
Why?
|
| Cysts | 1 | 2002 | 681 | 0.130 |
Why?
|
| DNA Probes | 2 | 2008 | 544 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2017 | 184 | 0.130 |
Why?
|
| Cell Line | 4 | 2021 | 15605 | 0.130 |
Why?
|
| beta Catenin | 3 | 2021 | 1040 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 11902 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2012 | 1699 | 0.130 |
Why?
|
| Interleukin-10 | 2 | 2015 | 1175 | 0.130 |
Why?
|
| Pharmacogenetics | 2 | 2011 | 675 | 0.130 |
Why?
|
| Genes, RAG-1 | 1 | 2015 | 67 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2016 | 285 | 0.130 |
Why?
|
| Air Pollution, Indoor | 2 | 2020 | 899 | 0.130 |
Why?
|
| Interleukin-6 | 3 | 2015 | 3207 | 0.130 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 8000 | 0.120 |
Why?
|
| Serotyping | 2 | 2006 | 325 | 0.120 |
Why?
|
| Recurrence | 4 | 2014 | 8469 | 0.120 |
Why?
|
| Microarray Analysis | 4 | 2014 | 749 | 0.120 |
Why?
|
| Neoplasms | 7 | 2015 | 22164 | 0.120 |
Why?
|
| Periodontitis | 1 | 2020 | 562 | 0.120 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2015 | 67 | 0.120 |
Why?
|
| Communicable Diseases, Emerging | 3 | 2006 | 148 | 0.120 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2015 | 87 | 0.120 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2014 | 10 | 0.120 |
Why?
|
| Mirabilis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Syndecan-4 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Interleukin-7 | 1 | 2015 | 142 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2016 | 256 | 0.120 |
Why?
|
| Rotenone | 1 | 2014 | 45 | 0.120 |
Why?
|
| Disease Outbreaks | 1 | 2004 | 1749 | 0.120 |
Why?
|
| Metabolic Clearance Rate | 1 | 2015 | 361 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2015 | 242 | 0.120 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2015 | 158 | 0.120 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2016 | 125 | 0.120 |
Why?
|
| Receptors, Somatomedin | 1 | 2014 | 56 | 0.120 |
Why?
|
| Immunoblotting | 2 | 2016 | 1647 | 0.120 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 519 | 0.120 |
Why?
|
| Blotting, Northern | 2 | 2006 | 1545 | 0.120 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 321 | 0.120 |
Why?
|
| Radiography, Thoracic | 2 | 2012 | 1302 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2009 | 632 | 0.110 |
Why?
|
| Psychometrics | 1 | 2004 | 3065 | 0.110 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 227 | 0.110 |
Why?
|
| Tumor Escape | 1 | 2017 | 370 | 0.110 |
Why?
|
| Rats | 4 | 2021 | 23742 | 0.110 |
Why?
|
| Quality of Life | 5 | 2018 | 13361 | 0.110 |
Why?
|
| HMGB1 Protein | 1 | 2015 | 137 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9179 | 0.110 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2014 | 317 | 0.110 |
Why?
|
| Drug Administration Schedule | 3 | 2012 | 4852 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 2057 | 0.110 |
Why?
|
| Germ-Line Mutation | 3 | 2019 | 1858 | 0.110 |
Why?
|
| Caregivers | 2 | 2018 | 2237 | 0.110 |
Why?
|
| Cell Transdifferentiation | 1 | 2014 | 185 | 0.110 |
Why?
|
| Thoracoscopy | 1 | 2014 | 180 | 0.110 |
Why?
|
| Residual Volume | 1 | 2013 | 41 | 0.110 |
Why?
|
| Enterovirus | 1 | 2014 | 67 | 0.110 |
Why?
|
| Regression Analysis | 3 | 2008 | 6343 | 0.110 |
Why?
|
| Sex Factors | 4 | 2015 | 10548 | 0.110 |
Why?
|
| Enterovirus Infections | 1 | 2014 | 74 | 0.110 |
Why?
|
| Gene Fusion | 1 | 2016 | 356 | 0.110 |
Why?
|
| Comorbidity | 3 | 2014 | 10498 | 0.110 |
Why?
|
| Cartilage, Articular | 1 | 2020 | 1099 | 0.110 |
Why?
|
| Trifluoperazine | 1 | 2012 | 37 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 20556 | 0.110 |
Why?
|
| Models, Biological | 4 | 2013 | 9469 | 0.110 |
Why?
|
| Treatment Failure | 2 | 2010 | 2642 | 0.110 |
Why?
|
| Sequence Alignment | 2 | 2008 | 2179 | 0.110 |
Why?
|
| Directly Observed Therapy | 1 | 2013 | 139 | 0.100 |
Why?
|
| Dimerization | 2 | 2011 | 891 | 0.100 |
Why?
|
| Macrophages | 1 | 2008 | 5768 | 0.100 |
Why?
|
| Genome, Human | 3 | 2020 | 4425 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 2691 | 0.100 |
Why?
|
| Epidermal Growth Factor | 1 | 2015 | 701 | 0.100 |
Why?
|
| Plethysmography | 1 | 2013 | 175 | 0.100 |
Why?
|
| Collagen Type IV | 1 | 2013 | 126 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 6 | 2018 | 6132 | 0.100 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2012 | 35 | 0.100 |
Why?
|
| Osteoarthritis | 1 | 2020 | 1060 | 0.100 |
Why?
|
| Thimerosal | 1 | 2012 | 15 | 0.100 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2014 | 269 | 0.100 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2012 | 85 | 0.100 |
Why?
|
| Fucosyltransferases | 1 | 2012 | 117 | 0.100 |
Why?
|
| Adolescent | 12 | 2014 | 88313 | 0.100 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2012 | 35 | 0.100 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3418 | 0.100 |
Why?
|
| Immediate-Early Proteins | 2 | 2006 | 449 | 0.100 |
Why?
|
| Incidence | 5 | 2015 | 21341 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2005 | 2163 | 0.100 |
Why?
|
| Hospital Mortality | 5 | 2010 | 5291 | 0.100 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 517 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 2416 | 0.100 |
Why?
|
| Phosphothreonine | 1 | 2012 | 62 | 0.100 |
Why?
|
| Narcotics | 1 | 2014 | 336 | 0.100 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 9031 | 0.100 |
Why?
|
| Tocopherols | 1 | 2011 | 44 | 0.100 |
Why?
|
| Tumor Burden | 2 | 2017 | 1890 | 0.100 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2013 | 785 | 0.100 |
Why?
|
| Protein Transport | 2 | 2015 | 1966 | 0.100 |
Why?
|
| Double-Blind Method | 3 | 2012 | 12330 | 0.100 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 146 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 13449 | 0.100 |
Why?
|
| Necrosis | 1 | 2016 | 1608 | 0.100 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2011 | 35 | 0.100 |
Why?
|
| Molecular Epidemiology | 1 | 2014 | 469 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2015 | 2448 | 0.100 |
Why?
|
| Antigens, Bacterial | 2 | 2007 | 1155 | 0.100 |
Why?
|
| Haplotypes | 2 | 2015 | 2775 | 0.100 |
Why?
|
| Heart Rate | 1 | 2003 | 4198 | 0.090 |
Why?
|
| Cricetulus | 1 | 2013 | 814 | 0.090 |
Why?
|
| Endocytosis | 1 | 2015 | 958 | 0.090 |
Why?
|
| Actinobacillus Infections | 1 | 2010 | 17 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 21012 | 0.090 |
Why?
|
| Genetic Markers | 2 | 2015 | 2613 | 0.090 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2012 | 274 | 0.090 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1090 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2003 | 2751 | 0.090 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 261 | 0.090 |
Why?
|
| Histocytochemistry | 1 | 2012 | 698 | 0.090 |
Why?
|
| Bone Neoplasms | 2 | 2020 | 2529 | 0.090 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2011 | 158 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2014 | 3712 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2014 | 360 | 0.090 |
Why?
|
| Radiography | 4 | 2009 | 6966 | 0.090 |
Why?
|
| Hemoptysis | 1 | 2012 | 152 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2014 | 498 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2012 | 8320 | 0.090 |
Why?
|
| Alleles | 4 | 2016 | 6922 | 0.090 |
Why?
|
| Transaminases | 1 | 2011 | 198 | 0.090 |
Why?
|
| CHO Cells | 1 | 2013 | 1388 | 0.090 |
Why?
|
| Azacitidine | 1 | 2012 | 336 | 0.090 |
Why?
|
| Cell Adhesion | 3 | 2013 | 3087 | 0.090 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2014 | 1444 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 6b | 1 | 2009 | 2 | 0.090 |
Why?
|
| Latent Tuberculosis | 1 | 2013 | 224 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2019 | 2571 | 0.090 |
Why?
|
| Genes, ras | 2 | 2013 | 654 | 0.090 |
Why?
|
| Transcription Factor AP-2 | 1 | 2010 | 80 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2014 | 562 | 0.080 |
Why?
|
| Radiotherapy Dosage | 2 | 2010 | 2898 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 1738 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1970 | 0.080 |
Why?
|
| Ubiquitination | 2 | 2011 | 1006 | 0.080 |
Why?
|
| Pancreatic Elastase | 1 | 2009 | 127 | 0.080 |
Why?
|
| Hepatic Insufficiency | 1 | 2009 | 14 | 0.080 |
Why?
|
| Neutropenia | 1 | 2015 | 884 | 0.080 |
Why?
|
| Epirubicin | 2 | 2008 | 81 | 0.080 |
Why?
|
| Cricetinae | 1 | 2013 | 2425 | 0.080 |
Why?
|
| Expressed Sequence Tags | 1 | 2010 | 250 | 0.080 |
Why?
|
| Binding Sites | 3 | 2013 | 6055 | 0.080 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 750 | 0.080 |
Why?
|
| Contact Tracing | 1 | 2011 | 271 | 0.080 |
Why?
|
| Tuberculosis, Pleural | 1 | 2009 | 13 | 0.080 |
Why?
|
| Inteins | 1 | 2008 | 9 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 7874 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 1135 | 0.080 |
Why?
|
| Dinucleotide Repeats | 1 | 2008 | 29 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3110 | 0.080 |
Why?
|
| Hypoventilation | 1 | 2009 | 44 | 0.080 |
Why?
|
| Gadolinium DTPA | 1 | 2012 | 823 | 0.080 |
Why?
|
| Osteonecrosis | 1 | 2010 | 229 | 0.080 |
Why?
|
| Prevalence | 3 | 2016 | 15717 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 4741 | 0.080 |
Why?
|
| DNA Glycosylases | 1 | 2009 | 125 | 0.080 |
Why?
|
| Liver | 1 | 2004 | 7532 | 0.080 |
Why?
|
| Telomere | 1 | 2014 | 941 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2013 | 3614 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 7595 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3522 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2009 | 754 | 0.080 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2008 | 63 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2018 | 1936 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1486 | 0.080 |
Why?
|
| Exercise Test | 2 | 2013 | 2129 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1115 | 0.070 |
Why?
|
| Radiosurgery | 1 | 2017 | 1342 | 0.070 |
Why?
|
| Rest | 1 | 2013 | 919 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2006 | 1651 | 0.070 |
Why?
|
| Chromatography | 1 | 2007 | 189 | 0.070 |
Why?
|
| Mycobacterium | 1 | 2009 | 251 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1791 | 0.070 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 1812 | 0.070 |
Why?
|
| Platinum Compounds | 1 | 2008 | 95 | 0.070 |
Why?
|
| Cisplatin | 3 | 2012 | 1650 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2010 | 459 | 0.070 |
Why?
|
| ROC Curve | 2 | 2013 | 3580 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2008 | 3446 | 0.070 |
Why?
|
| Mice, Inbred ICR | 1 | 2008 | 364 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2016 | 2010 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 2208 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2015 | 14409 | 0.070 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2009 | 144 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2011 | 1755 | 0.070 |
Why?
|
| Chest Pain | 1 | 2014 | 1090 | 0.070 |
Why?
|
| Pneumonectomy | 1 | 2014 | 1109 | 0.070 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2008 | 173 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 1420 | 0.070 |
Why?
|
| Anxiety | 2 | 2013 | 4572 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2021 | 11526 | 0.070 |
Why?
|
| Duodenal Ulcer | 1 | 2007 | 121 | 0.070 |
Why?
|
| Metered Dose Inhalers | 1 | 2006 | 25 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 546 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3702 | 0.070 |
Why?
|
| Multiple Organ Failure | 1 | 2009 | 387 | 0.070 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 836 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2010 | 8529 | 0.070 |
Why?
|
| Response Elements | 1 | 2008 | 309 | 0.070 |
Why?
|
| DNA Gyrase | 1 | 2007 | 85 | 0.070 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 1021 | 0.070 |
Why?
|
| Endocarditis, Bacterial | 1 | 2010 | 443 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2009 | 803 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4278 | 0.070 |
Why?
|
| Cefotaxime | 1 | 2006 | 35 | 0.070 |
Why?
|
| Sulbactam | 1 | 2006 | 31 | 0.070 |
Why?
|
| Captopril | 1 | 2007 | 265 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 558 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 15838 | 0.070 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2006 | 95 | 0.070 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2012 | 1208 | 0.070 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 197 | 0.070 |
Why?
|
| Risk | 4 | 2015 | 9612 | 0.070 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1393 | 0.070 |
Why?
|
| Terminal Care | 1 | 2018 | 1760 | 0.070 |
Why?
|
| Ampicillin | 1 | 2006 | 136 | 0.060 |
Why?
|
| Legionella pneumophila | 1 | 2006 | 49 | 0.060 |
Why?
|
| Drug Administration Routes | 1 | 2005 | 150 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 1863 | 0.060 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2005 | 195 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2012 | 1509 | 0.060 |
Why?
|
| Kallikreins | 1 | 2006 | 220 | 0.060 |
Why?
|
| Chemokine CXCL10 | 1 | 2006 | 316 | 0.060 |
Why?
|
| Vinblastine | 1 | 2007 | 488 | 0.060 |
Why?
|
| Computational Biology | 3 | 2015 | 3517 | 0.060 |
Why?
|
| YY1 Transcription Factor | 1 | 2005 | 60 | 0.060 |
Why?
|
| Anemia | 1 | 2015 | 1508 | 0.060 |
Why?
|
| DNA Methylation | 3 | 2016 | 4391 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 400 | 0.060 |
Why?
|
| Lung Abscess | 1 | 2005 | 40 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2012 | 928 | 0.060 |
Why?
|
| Bacteria, Anaerobic | 1 | 2005 | 70 | 0.060 |
Why?
|
| Decision Trees | 1 | 2007 | 504 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 422 | 0.060 |
Why?
|
| Gelatinases | 1 | 2004 | 88 | 0.060 |
Why?
|
| Patient Care | 1 | 2010 | 621 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 1265 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 1693 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22163 | 0.060 |
Why?
|
| Medical Records | 1 | 2010 | 1407 | 0.060 |
Why?
|
| CA-19-9 Antigen | 1 | 2005 | 106 | 0.060 |
Why?
|
| Mucin 5AC | 1 | 2005 | 96 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 2898 | 0.060 |
Why?
|
| Ventilators, Mechanical | 1 | 2007 | 288 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2881 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2012 | 2208 | 0.060 |
Why?
|
| Remission Induction | 1 | 2010 | 2395 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2013 | 3667 | 0.060 |
Why?
|
| Family | 2 | 2013 | 3197 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2006 | 451 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 4174 | 0.060 |
Why?
|
| Gangliosides | 1 | 2005 | 132 | 0.060 |
Why?
|
| Hospitalization | 1 | 2004 | 10718 | 0.060 |
Why?
|
| Disinfection | 1 | 2006 | 210 | 0.060 |
Why?
|
| Estrogens | 1 | 2011 | 1522 | 0.060 |
Why?
|
| Phenotype | 3 | 2018 | 16606 | 0.060 |
Why?
|
| Apolipoprotein A-I | 1 | 2005 | 299 | 0.060 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 662 | 0.060 |
Why?
|
| Antigens, Surface | 2 | 2005 | 1609 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 785 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 256 | 0.060 |
Why?
|
| Translations | 1 | 2004 | 81 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2007 | 570 | 0.060 |
Why?
|
| Beds | 1 | 2003 | 47 | 0.060 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 377 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2009 | 2048 | 0.050 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2004 | 187 | 0.050 |
Why?
|
| Collagen | 2 | 2009 | 2638 | 0.050 |
Why?
|
| Microcirculation | 2 | 2006 | 1273 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4370 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 14664 | 0.050 |
Why?
|
| Pneumococcal Vaccines | 1 | 2007 | 397 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2016 | 375 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2008 | 2667 | 0.050 |
Why?
|
| DNA Repair | 1 | 2012 | 2045 | 0.050 |
Why?
|
| Klebsiella pneumoniae | 1 | 2005 | 250 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2016 | 4650 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2009 | 1742 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1612 | 0.050 |
Why?
|
| Diaphragm | 1 | 2004 | 351 | 0.050 |
Why?
|
| Antioxidants | 2 | 2021 | 1669 | 0.050 |
Why?
|
| Intestines | 1 | 2011 | 1909 | 0.050 |
Why?
|
| Viruses | 1 | 2006 | 376 | 0.050 |
Why?
|
| Depression | 2 | 2013 | 8122 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 4575 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2218 | 0.050 |
Why?
|
| Proteomics | 1 | 2015 | 3845 | 0.050 |
Why?
|
| Acid Phosphatase | 1 | 2021 | 139 | 0.050 |
Why?
|
| Catenins | 1 | 2021 | 44 | 0.050 |
Why?
|
| Paclitaxel | 2 | 2007 | 1732 | 0.050 |
Why?
|
| Bronchial Fistula | 1 | 2002 | 83 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 1 | 2007 | 731 | 0.050 |
Why?
|
| Annexin A1 | 1 | 2020 | 21 | 0.050 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2020 | 115 | 0.050 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 1743 | 0.050 |
Why?
|
| Immunoprecipitation | 3 | 2010 | 878 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 1469 | 0.050 |
Why?
|
| Pleural Diseases | 1 | 2002 | 137 | 0.050 |
Why?
|
| Nausea | 1 | 2004 | 679 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2004 | 1340 | 0.050 |
Why?
|
| Deoxycytidine | 3 | 2012 | 877 | 0.050 |
Why?
|
| Air Pollutants | 1 | 2015 | 2881 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2005 | 1529 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2007 | 1937 | 0.040 |
Why?
|
| Coal | 1 | 2020 | 121 | 0.040 |
Why?
|
| Frizzled Receptors | 1 | 2020 | 90 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2021 | 613 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2008 | 1010 | 0.040 |
Why?
|
| Vomiting | 1 | 2004 | 652 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 1230 | 0.040 |
Why?
|
| Cytosine Deaminase | 1 | 2020 | 65 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 748 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2005 | 856 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2021 | 258 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2003 | 578 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 3030 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 3447 | 0.040 |
Why?
|
| Fistula | 1 | 2002 | 212 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2020 | 169 | 0.040 |
Why?
|
| Wound Healing | 1 | 2011 | 2803 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2005 | 2281 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1517 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4638 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2015 | 7956 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2006 | 1891 | 0.040 |
Why?
|
| Garlic | 1 | 2019 | 28 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2005 | 1330 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2851 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2021 | 260 | 0.040 |
Why?
|
| Ethambutol | 2 | 2009 | 59 | 0.040 |
Why?
|
| Age Distribution | 1 | 2005 | 2880 | 0.040 |
Why?
|
| DNA Primers | 3 | 2011 | 2820 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2006 | 2201 | 0.040 |
Why?
|
| Kidney | 1 | 2014 | 7049 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2012 | 3068 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 718 | 0.040 |
Why?
|
| Peptide Nucleic Acids | 1 | 2018 | 26 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2007 | 4016 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2004 | 746 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2021 | 432 | 0.040 |
Why?
|
| Glutathione | 1 | 2021 | 582 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4354 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2021 | 594 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2019 | 282 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 5789 | 0.040 |
Why?
|
| Gingiva | 1 | 2020 | 409 | 0.040 |
Why?
|
| Carcinogens | 1 | 2020 | 451 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2006 | 6231 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2011 | 3538 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2006 | 1393 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2006 | 2932 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 272 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2015 | 23990 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 10203 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 942 | 0.040 |
Why?
|
| Aging | 1 | 2016 | 8705 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2019 | 731 | 0.040 |
Why?
|
| Acrylamides | 1 | 2018 | 259 | 0.030 |
Why?
|
| Proteome | 1 | 2007 | 1862 | 0.030 |
Why?
|
| Asia, Southeastern | 1 | 2016 | 114 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36423 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2013 | 5970 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2019 | 656 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 1334 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2006 | 2047 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 1062 | 0.030 |
Why?
|
| Neutrophils | 1 | 2009 | 3766 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 982 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2006 | 5868 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8179 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 1171 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2020 | 795 | 0.030 |
Why?
|
| Adaptation, Psychological | 2 | 2018 | 2632 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2006 | 92 | 0.030 |
Why?
|
| Registries | 1 | 2011 | 8223 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 615 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 1808 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 4320 | 0.030 |
Why?
|
| Medicine, Tibetan Traditional | 1 | 2014 | 2 | 0.030 |
Why?
|
| Pneumonia | 1 | 2006 | 2140 | 0.030 |
Why?
|
| Heredity | 1 | 2015 | 148 | 0.030 |
Why?
|
| Hong Kong | 1 | 2014 | 166 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 2 | 2008 | 883 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 14599 | 0.030 |
Why?
|
| Pedigree | 2 | 2015 | 4589 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2014 | 107 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2016 | 430 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2021 | 2918 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2005 | 2985 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2014 | 294 | 0.030 |
Why?
|
| Singapore | 1 | 2014 | 291 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 3846 | 0.030 |
Why?
|
| Medical Waste | 1 | 2013 | 16 | 0.030 |
Why?
|
| Plant Roots | 1 | 2014 | 117 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6935 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2016 | 535 | 0.030 |
Why?
|
| Morbidity | 1 | 2019 | 1750 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2014 | 61 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2021 | 2415 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2014 | 76 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2019 | 1008 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2019 | 1253 | 0.030 |
Why?
|
| Penetrance | 1 | 2015 | 388 | 0.030 |
Why?
|
| Microvilli | 1 | 2013 | 234 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2018 | 1069 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 379 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.030 |
Why?
|
| Acute Disease | 1 | 2004 | 7238 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4172 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 330 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2014 | 571 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1405 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2012 | 56 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 84 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2011 | 6937 | 0.030 |
Why?
|
| Uterus | 1 | 2016 | 649 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2012 | 277 | 0.020 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2012 | 197 | 0.020 |
Why?
|
| Family Health | 1 | 2016 | 1257 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2013 | 370 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2012 | 361 | 0.020 |
Why?
|
| Sialic Acids | 1 | 2011 | 123 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2012 | 418 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2012 | 275 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 192 | 0.020 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2011 | 99 | 0.020 |
Why?
|
| Fucose | 1 | 2011 | 122 | 0.020 |
Why?
|
| Progestins | 1 | 2012 | 301 | 0.020 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 156 | 0.020 |
Why?
|
| Aromatase | 1 | 2011 | 147 | 0.020 |
Why?
|
| Japan | 1 | 2014 | 1371 | 0.020 |
Why?
|
| Pathology, Molecular | 1 | 2013 | 328 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 346 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 429 | 0.020 |
Why?
|
| Biosynthetic Pathways | 1 | 2011 | 136 | 0.020 |
Why?
|
| Oxygen | 1 | 2002 | 4228 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2010 | 148 | 0.020 |
Why?
|
| RNA | 2 | 2013 | 2723 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2014 | 638 | 0.020 |
Why?
|
| Streptomycin | 1 | 2009 | 69 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2012 | 366 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 6532 | 0.020 |
Why?
|
| Aza Compounds | 1 | 2009 | 34 | 0.020 |
Why?
|
| Ofloxacin | 1 | 2009 | 66 | 0.020 |
Why?
|
| Pyrazinamide | 1 | 2009 | 60 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 799 | 0.020 |
Why?
|
| Anilides | 1 | 2012 | 411 | 0.020 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2011 | 251 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1677 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 1098 | 0.020 |
Why?
|
| Piperazines | 1 | 2018 | 2523 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3093 | 0.020 |
Why?
|
| Isoniazid | 1 | 2009 | 283 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 2005 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2012 | 624 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2006 | 5127 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2009 | 416 | 0.020 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2008 | 122 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2009 | 615 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2012 | 1336 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 611 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3201 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 283 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2011 | 582 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 1156 | 0.020 |
Why?
|
| Stress, Psychological | 2 | 2013 | 4477 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 603 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2017 | 2637 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 8999 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 2009 | 499 | 0.020 |
Why?
|
| Introns | 1 | 2008 | 981 | 0.020 |
Why?
|
| Oximetry | 1 | 2009 | 460 | 0.020 |
Why?
|
| Heating | 1 | 2006 | 104 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1405 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 629 | 0.020 |
Why?
|
| Endonucleases | 1 | 2008 | 371 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1706 | 0.020 |
Why?
|
| Point Mutation | 1 | 2010 | 1596 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 2116 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 1596 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 2416 | 0.020 |
Why?
|
| Fatigue | 1 | 2012 | 1551 | 0.010 |
Why?
|
| Delayed Diagnosis | 1 | 2009 | 462 | 0.010 |
Why?
|
| Protein Multimerization | 1 | 2010 | 983 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 2009 | 639 | 0.010 |
Why?
|
| Causality | 1 | 2010 | 1243 | 0.010 |
Why?
|
| Computer-Aided Design | 1 | 2006 | 300 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1640 | 0.010 |
Why?
|
| Dyspnea | 1 | 2012 | 1347 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2009 | 1682 | 0.010 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2008 | 857 | 0.010 |
Why?
|
| Child | 3 | 2009 | 80162 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2009 | 42254 | 0.010 |
Why?
|
| Quinolines | 1 | 2009 | 764 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2927 | 0.010 |
Why?
|
| Klebsiella Infections | 1 | 2005 | 146 | 0.010 |
Why?
|
| Postmenopause | 1 | 2012 | 2513 | 0.010 |
Why?
|
| Acetylation | 1 | 2006 | 1055 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 1118 | 0.010 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 388 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2007 | 983 | 0.010 |
Why?
|
| Fibronectins | 1 | 2006 | 723 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2223 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 3792 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2005 | 473 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2734 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5246 | 0.010 |
Why?
|
| Syndrome | 1 | 2009 | 3268 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2006 | 1529 | 0.010 |
Why?
|
| Polysomnography | 1 | 2009 | 1847 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 2469 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 2510 | 0.010 |
Why?
|
| Data Collection | 1 | 2011 | 3322 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 461 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5439 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2010 | 2908 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2478 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 26112 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12970 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 3823 | 0.010 |
Why?
|
| Virus Diseases | 1 | 2006 | 719 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2012 | 3027 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 2192 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 7825 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6309 | 0.010 |
Why?
|
| Contrast Media | 1 | 2012 | 5311 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 4248 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 2269 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2011 | 3905 | 0.010 |
Why?
|
| Pain | 1 | 2013 | 5071 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3963 | 0.010 |
Why?
|
| Echocardiography | 1 | 2010 | 4991 | 0.010 |
Why?
|
| Weight Loss | 1 | 2009 | 2683 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6215 | 0.010 |
Why?
|
| Antibodies | 1 | 2005 | 2421 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 6581 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2010 | 4330 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2008 | 6238 | 0.010 |
Why?
|
| Vaccination | 1 | 2007 | 3381 | 0.010 |
Why?
|
| Infant | 1 | 2015 | 36205 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 26212 | 0.000 |
Why?
|